126 related articles for article (PubMed ID: 28119089)
21. MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.
Huang K; Tang Y; He L; Dai Y
Oncol Rep; 2016 Feb; 35(2):887-95. PubMed ID: 26718483
[TBL] [Abstract][Full Text] [Related]
22. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
[TBL] [Abstract][Full Text] [Related]
23. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis.
Chang TC; Wentzel EA; Kent OA; Ramachandran K; Mullendore M; Lee KH; Feldmann G; Yamakuchi M; Ferlito M; Lowenstein CJ; Arking DE; Beer MA; Maitra A; Mendell JT
Mol Cell; 2007 Jun; 26(5):745-52. PubMed ID: 17540599
[TBL] [Abstract][Full Text] [Related]
24. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA and targeted mRNA expression profiling analysis in human colorectal adenomas and adenocarcinomas.
Gattolliat CH; Uguen A; Pesson M; Trillet K; Simon B; Doucet L; Robaszkiewicz M; Corcos L
Eur J Cancer; 2015 Feb; 51(3):409-20. PubMed ID: 25586944
[TBL] [Abstract][Full Text] [Related]
26. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest.
Tarasov V; Jung P; Verdoodt B; Lodygin D; Epanchintsev A; Menssen A; Meister G; Hermeking H
Cell Cycle; 2007 Jul; 6(13):1586-93. PubMed ID: 17554199
[TBL] [Abstract][Full Text] [Related]
27. Target identification of microRNAs expressed highly in human embryonic stem cells.
Li SS; Yu SL; Kao LP; Tsai ZY; Singh S; Chen BZ; Ho BC; Liu YH; Yang PC
J Cell Biochem; 2009 Apr; 106(6):1020-30. PubMed ID: 19229866
[TBL] [Abstract][Full Text] [Related]
28. Loss of microRNA-143/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop.
Zhang J; Sun Q; Zhang Z; Ge S; Han ZG; Chen WT
Oncogene; 2013 Jan; 32(1):61-9. PubMed ID: 22330136
[TBL] [Abstract][Full Text] [Related]
29. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres.
Ji Q; Hao X; Meng Y; Zhang M; Desano J; Fan D; Xu L
BMC Cancer; 2008 Sep; 8():266. PubMed ID: 18803879
[TBL] [Abstract][Full Text] [Related]
30. Mutant p53 inhibits miRNA biogenesis by interfering with the microprocessor complex.
Garibaldi F; Falcone E; Trisciuoglio D; Colombo T; Lisek K; Walerych D; Del Sal G; Paci P; Bossi G; Piaggio G; Gurtner A
Oncogene; 2016 Jul; 35(29):3760-70. PubMed ID: 26996669
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional regulation of microRNA-100, -146a, and -150 genes by p53 and NFκB p65/RelA in mouse striatal STHdh(Q7)/ Hdh(Q7) cells and human cervical carcinoma HeLa cells.
Ghose J; Bhattacharyya NP
RNA Biol; 2015; 12(4):457-77. PubMed ID: 25757558
[TBL] [Abstract][Full Text] [Related]
32. The miR27b-CCNG1-P53-miR-508-5p axis regulates multidrug resistance of gastric cancer.
Shang Y; Feng B; Zhou L; Ren G; Zhang Z; Fan X; Sun Y; Luo G; Liang J; Wu K; Nie Y; Fan D
Oncotarget; 2016 Jan; 7(1):538-49. PubMed ID: 26623719
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-181a - a tale of discrepancies.
Seoudi AM; Lashine YA; Abdelaziz AI
Expert Rev Mol Med; 2012 Feb; 14():e5. PubMed ID: 22348355
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.
Corney DC; Flesken-Nikitin A; Godwin AK; Wang W; Nikitin AY
Cancer Res; 2007 Sep; 67(18):8433-8. PubMed ID: 17823410
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs.
He H; Wang L; Zhou W; Zhang Z; Wang L; Xu S; Wang D; Dong J; Tang C; Tang H; Yi X; Ge J
PLoS One; 2015; 10(5):e0125672. PubMed ID: 25938468
[TBL] [Abstract][Full Text] [Related]
36. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
Wang B; Li J; Sun M; Sun L; Zhang X
IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
[TBL] [Abstract][Full Text] [Related]
37. p53 Represses the Oncogenic Sno-MiR-28 Derived from a SnoRNA.
Yu F; Bracken CP; Pillman KA; Lawrence DM; Goodall GJ; Callen DF; Neilsen PM
PLoS One; 2015; 10(6):e0129190. PubMed ID: 26061048
[TBL] [Abstract][Full Text] [Related]
38. Limited role of N-terminal phosphoserine residues in the activation of transcription by p53.
Jackson MW; Agarwal MK; Agarwal ML; Agarwal A; Stanhope-Baker P; Williams BR; Stark GR
Oncogene; 2004 May; 23(25):4477-87. PubMed ID: 15064747
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis.
Chen QY; Jiao DM; Yan L; Wu YQ; Hu HZ; Song J; Yan J; Wu LJ; Xu LQ; Shi JG
Mol Biosyst; 2015 Aug; 11(8):2290-302. PubMed ID: 26075299
[TBL] [Abstract][Full Text] [Related]
40. Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma.
Yang Z; Yuan Z; Fan Y; Deng X; Zheng Q
Mol Med Rep; 2013 Nov; 8(5):1353-8. PubMed ID: 24064622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
